Does higher cortisol exposure increase hepatic glucose output and promote insulin resistance?

The physiological relationship between cortisol exposure and glucose metabolism is well-documented, operating through a bidirectional feedback loop that can lead to metabolic dysregulation. In a 33-year-old female, chronic activation of the stress response—mediated by the hypothalamic-pituitary-adrenal (HPA) axis—can significantly impact systemic insulin sensitivity and glycemic control.

Clinical evidence and mechanisms

• Hepatic Glucose Production: Cortisol directly increases hepatic glucose output (HGO) by acting as a transcriptional regulator of gluconeogenesis. It upregulates key enzymes, specifically phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase). In experimental settings, sustained cortisol elevation has been shown to increase glucose production by up to 100%, even in the presence of hyperinsulinemia, demonstrating its role in driving hepatic insulin resistance.
• Insulin Resistance: Chronic cortisol exposure antagonizes insulin action by promoting lipolysis and shifting energy storage toward visceral fat. Elevated cortisol levels correlate with higher HOMA-IR scores and inflammatory markers. Local amplification of cortisol by the enzyme 11β-HSD1 in adipose and liver tissues further exacerbates insulin resistance, hypertension, and dyslipidemia.
• Stress Physiology Reinforcement: Glycemic instability, particularly hypoglycemia (glucoprivic stress), acts as a potent trigger for the HPA axis. When blood glucose drops below critical thresholds (typically ~58 mg/dL), the HPA axis is activated to release ACTH and cortisol to restore euglycemia. Frequent glycemic oscillations can eventually impair the normal negative feedback mechanisms of the HPA axis, potentially leading to flattened diurnal cortisol rhythms and chronic stress physiology.

Mechanistic pathways

The molecular drivers of this cycle involve the glucocorticoid receptor (GR) translocating to the nucleus to activate Pck1 and G6pc genes. This process is further amplified by coactivators such as CRTC2 and regulated by kinases like SGK1. Notably, SGK1 promotes glucose output by inhibiting AMP-activated protein kinase (AMPK), which would otherwise suppress gluconeogenesis.

Bottom line

The claim is strongly supported by science. Higher cortisol exposure increases hepatic glucose output and drives insulin resistance, while the resulting glycemic instability—especially low-glucose events—triggers further HPA axis activation, creating a self-reinforcing cycle of metabolic and physiological stress.